Treating lung cancer is more precise than ever, thanks to biomarker testing, which gives clinicians a better understanding of individual’s tumors.
Biomarker Testing in Lung Cancer Continues to Improve Outcomes, Move the Field Forward
Years ago, many patients with lung cancer were treated the same, as there was limited knowledge about the disease and limited therapies to treat it. Then, biomarker testing brought precision medicine into the world of lung cancer, and now patients are treated with drugs specifically designed to treat cancer with certain characteristics.